Clinical trial
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal…
NCT00003548 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00003548 |
|---|---|
| Title | Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity |
| Official title | Phase I Study of Intraperitoneal Administration of 9-Amino-20(S)-Camptothecin to Patients With Cancer Predominantly Confined to the Peritoneal Cavity |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | aminocamptothecin colloidal dispersion |
| Enrollment | 20 |
| Start date | Aug 1, 1998 |
| Primary completion | Dec 1, 2001 |
| First posted | Feb 20, 2004 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: